9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

download 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

of 128

Transcript of 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    1/128

    PULP THERAPY INPRIMARY TEETH

    Dr Feda ZawaidehBDS, ADC(Vic), GradDipClinDent, DClinDent(Melb), FRACDS,

    FRACDS (Paed), JDB

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    2/128

    PULP BIOLOGY

    Pulp-dentine complex

    Primary dentinogenesis

    Secondary dentinogenesis

    Tertiary dentinogenesis

    Reactionary dentine

    Reparative dentine

    Tziafas, Smith, Lesot. Designing new treatment strategies in vi tal pulp therapy.

    Journal of Denti stry 2000; 28: 77-92.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    3/128

    Tziafas, Smith, Lesot. Designing new treatment strategies in vi tal pulp therapy.

    Journal of Dentistry 2000; 28: 77-92.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    4/128

    PULP THERAPY

    The goal of pulp therapy in the primary& mixed dentitions are:

    Successful treatment of the cariously

    involved pulp to maintain the tooth in a non-pathological state

    Maintenance of arch length and tooth space

    Restoration of comfort with the ability to

    chew Prevention of speech abnormalities and

    abnormal habits

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    5/128

    INDICATIONS &

    CONTRAINDICATIONS OF

    PULP THERAPY

    Factors influencing the decision to retain

    primary teeth:

    Medical history

    Behaviour factors

    Dental factors

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    6/128

    MEDICAL HISTORY

    CONTRAINDICATIONS:

    Congenital cardiac disease

    Immunosuppressed patients

    Children with poor healing potential

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    7/128

    MEDICAL HISTORY

    INDICATIONS:

    Bleeding disorders and coagulopathies

    Oligodontia as in Ectodermal

    Dysplasia

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    8/128

    BEHAVIOUR FACTORS

    CONTRAINDICATIONS:

    Uncooperative or non-compliant

    patient/parent

    INDICATIONS:

    Dentally aware patient/family

    Cooperative child

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    9/128

    DENTAL FACTORS

    CONTRAINDICATIONS:

    Grossly neglected dentition

    Acute odontogenic infection

    Unrestorable tooth

    Advanced tooth mobility/rootresorption

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    10/128

    DENTAL FACTORS

    INDICATIONS:

    Well-maintained arch with intact

    primary dentition Orthodontic considerations and space

    maintenance

    Lack of a permanent successor

    Minimal root resorption and nomobility

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    11/128

    CASE ASSESSMENT

    Chief complaint and pain history

    - Area involved

    - Duration of the problem- Precipitants and relieving factors

    - Duration of pain

    - Spontaneous or precipitated by a

    stimulus- Analgesia required

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    12/128

    CASE ASSESSMENT

    Medical history

    Dental history and attitude totreatment

    Clinical examination Special tests

    - Pulp sensitivity tests

    - Mobility and tenderness onpercussion

    - Radiographic examination

    - Direct visual examination of the pulp

    chamber

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    13/128

    PULPAL DIAGNOSIS

    Healthy

    Reversible pulpitis

    Irreversible pulpitis

    Total pulp necrosis

    Differentiation between reversible and

    irreversible pulpitis is extremely

    difficult

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    14/128

    PULP THERAPY OPTIONS

    Conservative or vital

    pulp therapy

    - Indirect pulp treatment- Direct pulp treatment

    - Pulpotomy

    Radical or non-vital pulptherapy

    - Pulpectomy

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    15/128

    DIRECT PULP CAPPING

    The placement of a dressing or

    medicament on a pulp exposure in an

    attempt to preserve pulp vitalityIt is generally not recommended in

    primary molars due to its un

    predictable results, high failure rateand high incidence of internal

    resorption or acute dentoalveolar

    abcesses

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    16/128

    INDIRECT PULP

    TREATMENT

    The procedures or steps taken to

    protect or maintain the vitality of

    the carious tooth that, ifcompletely excavated, the decay

    would result in a pulp exposure

    Al -Zayer M . Pediatr ic Dentistry, 25(1): 29-36, 2003

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    17/128

    INDIRECT PULP

    TREATMENT

    Indicated in an asymptomatic tooth

    that has a carious lesion near the

    dental pulp, a protective dressing orcement is placed over a layer of the

    remaining carious dentine to prevent

    pulpal exposure and stimulate healingand repair

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    18/128

    INDIRECT PULP

    TREATMENT

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    19/128

    INDIRECT PULP

    TREATMENT

    All caries at the DEJ must be removed

    Remove the infected dentine

    (superficial layer)This layer contains the majority of

    microorganisms and their toxic products that are also the source ofcontinuous insult to the pulp. The infected layer must be removed

    to allow the healing of the dental pulp.

    Leave the affected layer (the deep

    decalcified layer)this layer has only a few microorganisms. The affected layer can be left in

    place without any adverse effect on the dental pulp

    Apply liner/base

    Restore the tooth

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    20/128

    Clinical Technique

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    21/128

    INDIRECT PULP

    TREATMENT

    Re-entry into the cavity after 6-12

    months demonstrated no evidence of a

    pulp exposure, the existence of onlyfew microorganisms (reduced by 70-

    100%), medium to hard consistency of

    the residual dentine

    Al-Zayer M. Pediatric Dentistry, 25(1): 29-36, 2003

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    22/128

    INDIRECT PULP

    TREATMENT

    Re-entry into the cavity has been

    questioned especially if a durable

    restoration is placed initially and noadverse symptoms develop

    An excellent coronal seal is required to

    ensure good success rate with thistechnique

    Stepwise excavation technique-re-

    entry in 2-3 weeks (unjustified)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    23/128

    Stepwise Excavation

    Bjorndal L . Indirect pulp therapy and stepwise excavation. Pediatr ic Denti stry 2008;

    30:225-9.

    Diagrams demonstrating the

    less invasive stepwise excavation

    procedure. A closed lesion

    environment before and after

    first excavation (a, b) followed

    by a calcium hydroxide

    containing base material and aprovisional restoration. During

    the treatment interval the

    retained demineralized dentin

    has clinically changed into signs

    of slow lesion progress,

    evidenced by a darker

    demineralized dentin (c, d).

    After final excavation (e) the

    permanent restoration is made

    (f ). Red zones indicate plaque.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    24/128

    Example of using glass ionomer caries control to diagnose reversible

    pulpitis or food impaction in a mandibular first primary molar with

    a history of pain to chewing sweets and solid foods for 23 weeks. (a)

    Preoperative view. (b) Preoperative radiograph. (c) View

    immediately after glass ionomer placement. (d) Two months after

    caries control. Pain stopped from day glass ionomer placed. No

    clinical or radiographic sign of irreversible pulpitis. (e) View of IPT

    with a glass ionomer base. (f ) Tooth 16 months after treatment

    without signs of pain or irreversible pulpitis clinically or on the

    radiograph.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    25/128

    Prognosis

    Variable 75-100%, recent studies over 90%

    Farooq et al (2000) using GIC for IPT had

    a success rate of 93% vs single visitpulpotomy with formocresol 74% followed

    for 2-7 years

    In addition, formocresol puloptomy

    hastened the exfoliation of treated primarymolars whereas IPT did not

    Al-Zayer et al (2003) had a success rate of

    95%

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    26/128

    INDIRECT PULP

    TREATMENT

    Success rates improved when:

    A base is used over the liner

    A SSC is used to restore the tooth

    Treatment performed on second

    primary molar than a first primary

    molar

    Al-Zayer M. Pediatric Dentistry, 25(1): 29-36, 2003

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    27/128

    INDIRECT PULP

    TREATMENT

    The ideal material for vital pulp treatment should

    be able to resist long-term bacterial leakage and

    stimulate the remaining pulp tissue to return to a

    healthy state, promoting the formation of dentin

    Materials used

    - Calcium hydroxide Cement (CH)

    - Zinc Oxide Eugenol Cement (ZOE)

    - Glass Ionomer Cement (GIC)

    - Adhesive resin system

    - MTA

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    28/128

    Radiographic evaluation of a mandibular first and second primary molar that received indirect pulp

    treatment with adhesive resin only and were considered successful outcomes after 2 years. Preoperative

    radiograph (a), immediate postoperative (b), and 6 months (c), 12 months (d), 18 months (e) and 24

    months (f) after indirect pulp treatment.

    Radiographic evaluation of a mandibular first primary molar that received indirect pulp treatment with adhesive

    resin only and was considered a failure after 18 months. Preoperative radiograph (a), immediate postoperative (b),

    and 6 months (c), 12 months (d) and 18 months (e) after indirect pulp treatment. The interradicular lesion

    accompanied by external and internal root resorption observed in panel (e) was indicative of treatment failure.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    29/128

    Radiographic evaluation of a mandibular second primary molar that received indirect pulp treatment with

    calcium hydroxide and was considered a successful outcome after 2 years. Preoperative radiograph (a),

    immediate postoperative (b) and 6 months (c), 12 months (d), 18 months (e) and 24 months (f) after IPT

    Radiographic evaluation of a mandibular second primary molar that received indirect pulp treatment with calcium

    hydroxide and was

    considered a failure after 18 months. Preoperative radiograph (a), immediate postoperative (b) and 6 months (c), 12

    months (d) and 18 months (e)

    after indirect pulp treatment. The interradicular lesion accompanied by external root resorption observed in panel (e)was indicative of treatment failure.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    30/128

    PULPOTOMY

    Involves the amputation of the coronal

    portion of the affected or infected dental

    pulp. Treatment of the remaining vital

    radicular pulp tissue surface should

    preserve the vitality and function of all or

    part of the remaining radicular portion of

    the pulp. The coronal pulp chamber is filled

    with a suitable base and the tooth restored

    The American Academy of Pediatric Dentistry Reference

    Manual

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    31/128

    PULPOTOMY

    Indications:

    Large carious lesion involving more

    than 1/3 of marginal ridge in a

    restorable tooth

    Vital tooth free of radicular pulpitis

    with pain of short duration, no

    swelling, mobility, tenderness or pus

    discharge, no periapical pathosis or

    inter-radicular bone loss

    At least 2/3 of root remaining

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    32/128

    PULPOTOMY

    Clinical contraindications:

    Unrestorable tooth

    History of spontaneous/persistent pain

    Irreversible pulpitis or pulp necrosis

    Pus discharge

    Pathological mobility Swelling of pulpal origin

    Sinus tract or fistula

    Hyperaemic pulp

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    33/128

    PULPOTOMY

    Radiographic contraindications:

    External or internal root resorption

    Periapical or furcal pathology

    Radicular bone loss

    Pulp calcification

    Less than 2/3 root left Permanent tooth close to eruption

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    34/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    35/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    36/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    37/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    38/128

    PULPOTOMY MATERIALS

    Ranly D 1994 stated that pulpotomy therapy has

    been developed along three lines according to the

    method of action of the material used:

    1. Devitalization with the use of formocresol and

    electrosurgery where the intent is to destroy the

    radicular pulp

    2. Preservation of the remaining radicular pulp with

    the use of gluteraldehyde and ferric sulphate

    3. Regeneration of the radicular pulp by stimulation

    of a dentinal bridge that, in humans, has been

    accomplished with the use of calcium hydroxide,

    MTA and bone morphogenic proteins and enamel

    matrix proteins

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    39/128

    PULPOTOMY-MATERIALS

    Formocresol

    Ferric sulphate

    Gluteraldehyde

    CH cement

    Ledermix Cement

    Sodium Hypochlorite

    Electrosurgery

    Laser therapy

    Mineral Trioxide Aggregate (MTA)

    Bone morphogenic proteins (BMPs)

    FORMOCRESOL

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    40/128

    FORMOCRESOL

    PULPOTOMY

    Buckleys Formocresol

    Tricresol-35%

    Formaldehyde-19%glycerol-15%

    water-31%

    1:5 dilution

    The pulp remains half dead, half vital, and

    chronically inflamed.

    Success rate ranges from 70-97% but

    diminishes with time.

    O OC SO

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    41/128

    FORMOCRESOL

    PULPOTOMY

    Fixation of the pulp

    tissue by direct contact

    Bactericidal

    3 layers form: fixation,coagulation necrosis,

    vital tissue

    Concern regarding

    systemic toxicity,

    carcinogenicity and

    mutagenicity

    Successrate:70-100%

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    42/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    43/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    44/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    45/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    46/128

    Irrigate the pulp chamber with saline to remove debris

    Control the haemorrhage with slightly damped cotton

    wool pledget

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    47/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    48/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    49/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    50/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    51/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    52/128

    FERRIC SULPHATE

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    53/128

    FERRIC SULPHATE

    PULPOTOMY

    Was first used with CH to aid in the control

    of haemorrhage, now used without CH

    A ferric ion complex is formed in contact

    with blood which promotes haemostasis

    Clinically proven to be as effective as

    Formocresol

    Less toxic

    GLUTERALDEHYDE

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    54/128

    GLUTERALDEHYDE

    PULPOTOMY

    Rapid fixation of the pulp tissues

    Less penetration into the periapical

    tissues Toxicity concerns

    Eye irritation and allergic reaction

    Short shelf life

    Higher success rates than Formocresol

    CALCIUM HYDROXIDE

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    55/128

    CALCIUM HYDROXIDE

    PULPOTOMY

    Antibacterial activity

    Surface layer of coagulation necrosis

    Associated with high rates of internalresorption

    Success rate of 60%

    Recently questioning low success rateattributing that to incorrect diagnosis

    and contact with the blood clot

    T t t O t ith diff t

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    56/128

    Treatment Outcome with different

    agents

    When outcomes of ferric sulphate were compared to ZOE RCTs

    at 2 & 3 year follow up periods following carious exposures in

    primary teeth, the reported outcomes for FS were poorer than RCT

    outcomes at 2 years; however, at 2 years, the survival rates were not

    statistically different. On the other hand, no statistical difference inoutcomes was demonstrated at 3-year assessment, however, RCT-

    treated molars demonstrated significantly greater survival than FS

    treated molars 3 years after treatment. Casas et al ( 2002 & 2003)

    Pulpotomies performed with either FC or FS are likely to have

    similar clinical and radiographic successes. The mean clinical andradiographic success rates of treatment with ferric sulphate were

    91.6% and 73.5%, respectively. Due to the deleterious effect of FC,

    it is suggested that FS be recommended as a replacement. (Peng

    2007)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    57/128

    MTA

    Mineral trioxide aggregate (MTA):

    It has excellent sealing ability, biocompatibe, induces hard

    tissue formation, has antimicrobial properties, maintains pulp

    integrity & promotes healing without cytotoxic effect, It hashigher long term clinical and radiographic success rate than

    pulp dressing materials like FC.

    MTA is a powder composed of a mixture of a refined Portland

    cement and bismuth oxide, reported to contain trace amounts

    of SiO2, CaO, MgO, K2SO4, and Na2SO4.

    MTA powder is mixed with sterile water in a 3:1 powder/liquid

    upon hydration, a colloidal gel is formed that solidifies to a

    hard structure in approximately 34h, with moisture from the

    surrounding tissues assisting the setting reaction.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    58/128

    Hydrated MTA products have an initial pH of 10.2, which

    rises to 12.5 three hours after mixing. MTAs compressive

    strength after setting is 70 Mpacomparable to that of IRM

    and Super-EBA but less than that of amalgam.

    Preparation with saline and 2% lidocaine anesthetic solution

    increases setting time without significantly affecting the

    compressive strength.

    Ragarding leakage, MTA frequently performs better thanamalgam, IRM or Super EBA. Compared with composite

    resins placed under ideal conditions, MTAs leakage patterns

    are similar & the presence of blood has little impact on the

    degree of leakage.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    59/128

    (GMTA) and White MTA (WMTA) have been introduced.

    WMTA has a lighter color, smaller particle size, being

    significantly less soluble & more radiopaque than GMTA.

    MTA vs FC: procedure requires less time & risk of re-

    bleeding is absent.

    MTA is costly, it cannot be kept once the envelope is opened

    so its use in pediatric dentistry becomes almost prohibitive.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    60/128

    Evidence on MTA

    MTA vs FC:

    MTA-treated teeth showed no clinical or radiographic

    pathology whereas internal resorption was detected in the FC

    group after follow up periods ranging from 6-30 months .(Eidelman & Holan 2000)

    The success rate of pulpotomy was 97% for MTA and 83%

    for FC after a follow up period of 74months , internal

    resorption occurred more in FC pulpotomy. (Holan 2005)

    MTA was superior to FC in pulpotomy and might be FCs

    suitable replacement resulting in a lower failure rate & lower

    undesirable responses. (Peng 2006)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    61/128

    GMTA vs WMTA & FC:

    GMTA appeared to be better than WMTA and FC because

    it presented the closest to normal pulp architecture.

    (Agamy 2004)

    FC vs FS, WMTA ,WPC :

    Beta-TCP, WMTA are histologically more effective

    pulpotomy agents than FC and FS in primary pig teeth since

    FC & FS provoked more pulp inflammatory response.

    (Shayegan 2008)

    E l M t i D i ti (EMD)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    62/128

    Enamel Matrix Derivative (EMD)

    Emdogain gel has been successfully employed for

    pulpotomies in noninfected teeth in animal studies. Its effect

    was also investigated on experimentally exposed human

    permanent pulps, but seems ineffective for formation ofhard tissue barriers.

    Emdogain gel is a bioinductive material that is compatible

    withvital human tissues. It offers a good healing potential

    and is capable of inducing dentin formation, leaving theremaining pulp tissue healthy and functioning, it may act in

    a multitude of ways on mesenchymal cells that provide pulp

    protection. (Sabbarini 2006)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    63/128

    EMD vs FC: success rates at 6 months didnt differ.

    However, after 6 months the radiographic success rates for

    FC and EMD were 13% and 60 %, respectively. EMD-

    treated teeth had less periodontal membrane widening, lessperiapical and/or furcation Radiolucencies & no pulp

    calcifications. Therefore, When compared with FC, EMD

    appears to be clinically and radiographically superior.(Sabbar ini 2008)

    EMD disadvantages: difficult application due to the gel

    consistency, almost impossible to condense any material over

    it, the whole amount of gel should be used within 2 hours or

    it will lose its effect therefore its not cost effective.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    64/128

    Calcium Hydroxide: pulpal repair vs internal resorption,

    success rate reaches 70%.

    The greater the area of carious exposure, the lower the

    success rate in pulpotomies at follow up period of 1 year.

    Internal resorption being the main reason for failure,

    however, it was not affected by physiological root resorption.(Snmez 2007)

    When Ca(OH)2was compared to FC, FS & MTA inpulpotomies at a follow up period of 2 years, the success rate

    was 76.9% for FC, 73.3% for FS, 46.1% for Ca(OH)2, and

    66.6% for MTA. Therefore, Ca(OH)2is less appropriate for

    primary teeth pulpotomies than the other pulpotomy agents.(Snmez 2008)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    65/128

    ND:YAG vs FC pulpotomy

    Nd:YAG laser may be considered as an alternative

    to formocresol for pulpotomies in primary teeth

    giving success rates of 85.71% & 71.42% vs90.47% for FC pulpotomy at 12 months.

    (Odabas 2007)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    66/128

    B4 ttt with ND:YAG 9 months after ttt 36 months after ttt

    I nternational Congress Ser ies 1248 (2003):

    251256

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    67/128

    PULPOTOMY-PROGNOSIS

    Regardless of the

    material used

    success depends on

    pulp status

    Reasons for failure:

    - Incorrect diagnosis

    - Inadequate coronalseal

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    68/128

    PULPECTOMY

    Involves gaining access to the root

    canals which are then debrided,

    enlarged and disinfected. The canals

    are filled with a resorbable material

    The American Academy of Pediatric Dentistry Reference Manual

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    69/128

    PULPECTOMY

    Indications:

    Tooth with irreversible pulpitis or

    necrotic pulp tissue Non-vital tooth with prolonged history

    of pain, swelling, mobility,

    radiolucency involving the furcationarea

    Persistent bleeding during a

    pulpotomy

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    70/128

    PULPECTOMY

    Contraindications:

    Periradicular involvement extending

    to the permanent tooth bud Pathological resorption of > 1/3 root

    Excessive internal root resorption

    Perforation of the floor of the pulpchamber

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    71/128

    Table. Root canal length of maxillary

    incisors and mandibular molars

    Length in mm

    Mean RangeTooth

    Central 16.5 16-17

    Lateral 15 14-16

    Tooth and

    Canal

    First molar

    Mesiobuccal 16.4 15-17Mesiolingual 14.2 9-15

    Distobuccal 13.1 12-15

    Distolingual 12.7 10-15

    Second molar

    Mesiobuccal 15.8 13-17

    Mesiolingual 14.4 11-16

    Distobuccal 14.9 13-16

    Distolingual 14.9 12-16

    I n 1992, Salama et al

    attempted to determine the

    length of the root canals of

    pr imary maxi l lary incisors

    and mandibular molars

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    72/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    73/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    74/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    75/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    76/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    77/128

    Step 6: Dry the canals

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    78/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    79/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    80/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    81/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    82/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    83/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    84/128

    TWO-STAGE PULPECTOMY

    Presence of an acute abscess

    Persistence of discharge

    Patient is in pain 2 stage pulpectomy with Formocresol

    intermediate dressing and antibiotics

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    85/128

    Criteria for an ideal filling in primary teeth

    It should resorb at the same rate as the primary root;

    be harmless to periapical tissue and the permanent tooth

    germ;

    resorb readily if pressed beyond the apex;

    be antiseptic;

    easily fill the canals and adhere to canal walls;

    not shrink; be easily removed;

    be radiopaque;

    not discolor the tooth; and be nontoxic.

    Historical re ie of root filling materials for

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    86/128

    Historical review of root filling materials for

    primary teeth

    Pure ZOE.

    A mixture of ZOE with formocresol and glycerine.

    Iodoform paste.

    Kri paste; a mixture of iodoform, camphor, parachlorophenol &

    menthol.

    The Overall success rate for KRI paste was 84% versus 65% for

    ZOE, Overf i l l ing with ZOE led to a failure rate of 59% as

    opposed to 21% for KRI , Conversely, underf i l l ing led to similar

    resul ts, with a failure rate of 17%f or ZOE and 14% for KRI .

    (Holan & Fuks 1993)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    87/128

    Vitapex, a commercial

    product containing a viscous

    mix of calcium hydroxide

    and iodoform in a syringewith disposable tips. The

    main ingredients are

    iodoform, calcium

    hydroxide, and silicone.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    88/128

    Pediatr Dent 2000; 22:517-520.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    89/128

    Vitapex vs ZOE: Vitapex appears to resolve

    furcation pathology at a faster rate than ZOE at 6

    months as demonstrated by a success rate of 78%

    vs 48%, while at 12 months, both materials yield

    similar results of 89% vs 85%.

    (Trairatvorakul 2008)

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    90/128

    Failure of zinc oxide-eugenol (ZOE) long-filled tooth.

    (A)Immediate postoperative X-ray of ZOE-overfilled primary mandibular RT Dshowing thickening of periodontal space at the furcation area.

    (B) Accelerated resorption of supporting bone at 6 months, showing large

    radiolucent area at the furcation and resorption of the entire mesial root

    considered a failure at 6 months.

    (C) Retained ZOE with premature eruption of the first premolar.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    91/128

    Failure of zinc oxide-eugenol-treated tooth at 6 months, which turned out

    to be successful at 12 months.

    (A)Immediate postoperative X-ray of primary mandibular RT E withradiolucency involving more than half of the distal root length.

    (B) At 6 months, although there is an increase in radiopacity of the

    furcation area from bone regeneration, the tooth was considered a

    failure due to a large rarefied area at the mesial root apex involving the

    crypt of the underlying permanent tooth bud.

    (C) At 12 months, the consistent radiopacity of the furcation area and thecomplete resolution of the rarefied area at the mesial root along with

    reunion of bony crypt walls of first premolar. The fulfillment of these 2

    criteria constitutes success.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    92/128

    Root filling materials for primary teeth, Contd

    Calcium hydroxide pastes:

    Sealapex showed less leakage than ZOE and Apexit in sealer-

    only obturation of pulpectomized primary teeth. (Kielbassa 2006)

    The overall success rate for sealapex was 92.3% during a follow-

    up period of 3 years, sealapex didnt show evidence of complete

    resorption in the canals. (Sar 2008)

    Maisto paste; similar to kri paste but with added thymol & ZnO.

    PROBLEMS IN PULP

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    93/128

    THERAPY

    Pain/poor patient cooperation

    Acute infection

    Persistent draining sinus

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    94/128

    RESTORATIONS

    Ideally SSC

    Amalgam

    Resin-modified GIC Composite resin

    SEQUELAE OF PULP

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    95/128

    THERAPY

    Effect on eruption time of permanent

    successor

    Enamel defects on permanentsuccessor possible related to the pre-

    exciting infection

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    96/128

    Stainless Steel Crown

    procedures for PrimaryMolars

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    97/128

    Indications

    Extensive caries

    Pulpotomy/pulpectomy

    Malformed teeth

    Hypoplasia

    Hereditary Conditions (AI, DI) If used as an attachment for

    a crown and loop SM

    Habit-breaking Appliance

    Distal Shoe appliance

    Fractured teeth Severe attrition of primary teeth

    Mesial lesions on first primary molars

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    98/128

    Contraindications

    Esthetics

    Teeth that are nearing exfoliation

    Mechanical problems

    space loss

    caries beneath the level of the bone

    Permanent restoration in the permanent

    dentition

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    99/128

    Use of Stainless Steel Crowns

    Introduced to pediatric dentistry by Dr. WilliamHumphrey in 1950

    prior to that orthodontic bands filled withamalgam were a last resort

    necessity is the mother of invention

    Considered superior to large multisurface amalgamrestorations and have a longer clinical lifespan thantwo or three surface amalgams (Dawson et al., 1981)

    Composition of Stainless Steel

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    100/128

    Crowns

    Alloy: nickel- chrome (ion crowns, 3M)

    77% nickel

    15% chromium

    7% iron

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    101/128

    What you will need

    Burs and Stones

    Flame shaped diamond (Occlusal reduction)

    Tapered diamond (Proximal reduction)

    Heatless stone

    Pliers and instruments

    Crimping plier

    Contouring plier Polishing

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    102/128

    Step By Step

    Caries Removal

    Complete pulp therapy if necessary

    Proceed with crown preparation

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    103/128

    Overview

    Occlusal reduction

    Proximal reduction

    Buccal and Lingual

    reduction

    Beveling

    Round all sharp line

    angles and corners

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    104/128

    Occlusal Reduction

    1.01.5 mm

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    105/128

    Completed Occlusal Reduction

    Check reduction with

    opposing arch

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    106/128

    Proximal Reduction

    Contact with adjacent teeth must be broken gingivally

    and buccolingually

    proximal slices converge slightly toward the occlusal

    and lingual

    DO NOT OVER TAPER

    The gingival margins should have a feather-edge finish

    line

    Adjacent tooth structure must not be damaged

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    107/128

    Proximal Slices

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    108/128

    Angulation of Slices

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    109/128

    Ledging

    Proximal slice must be

    extended below tissue to

    avoid leaving a ledge

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    110/128

    Buccal-Lingual Reduction

    Reduction is optional and is undertaken only if thebuccal or lingual bulges are so prominent that theconstricted margin of the crown will not go over heheight of contour

    When required, no more than .5-1mm should beremoved

    Reductions must end in a feather edge

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    111/128

    Beveling

    A bevel at an angle of 30-45 degrees removes

    the sharp cusp tips and creates a gentle slope

    in the occlusal third of the lingual and buccal

    surfaces

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    112/128

    Round Sharp Line Angles

    The buccal and lingual proximal line angles

    are rounded by holding the bur parallel to the

    tooths long axis and blending the surfaces

    together The finished contour should conform to the

    internal contour of the stainless steel crown

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    113/128

    Round Sharp Line Angles

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    114/128

    Selection of the Crown

    Goal:to place the smallest crown that can beseated on the tooth and to establish pre-existing proximal contacts

    Hint: Size 4 is the most frequently used crownsize for molars

    The selected crown is seated ligually firstthen buccally.

    Friction should be felt as the crown slips over thebuccal surface into the gingival sulcus

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    115/128

    C Ad i

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    116/128

    Crown Adaptation

    Mark gingival line with ascaler and trim 1 mm

    beneath the mark using C& B scissors.

    Margins should be trimmedto lie parallel with thecontour of the gingivaltissue and consist of a seriesof curves without sharp

    angles.

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    117/128

    Gingival Contours

    Buccal gingival contour of second primary molar--

    smile

    Buccal gingival contour of first

    primary molar-- stretched-out S

    Proximal gingival contour of

    primary molars --frown

    C h C

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    118/128

    Contour the Crown

    Use contouring pliers,

    bend the gingival third

    of the crowns margins

    inward to restoreanatomic margins and

    to reduce the marginal

    circumference ensuring

    a good fit

    C i h

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    119/128

    Crimp the crown

    With the crown-

    crimping plier (ball &

    socket plier) crimp the

    margin

    Replace crown on tooth

    and check margins with

    an explorer

    G id li

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    120/128

    Guidelines

    Resistance in seating without tissue blanching.

    Check for

    high spots on occlusal surface

    ledges

    Resistance in seating with tissue blanching.

    Check for

    crown too wide (preliminary contouring)

    crown too long

    tissue caught in margin

    Fi i hi d P li hi

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    121/128

    Finishing and Polishing

    Use heatless stone to

    smooth jagged edges

    Then use a rubber

    wheel to remove smallscratches and make it

    smooth

    Polish surface of crown

    to a high shine withtripoli and rouge

    C t ti

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    122/128

    Cementation

    Clean crown and tooth

    Fill crown with the

    appropriate cement

    Seat crown, expressing

    cement form all marginsand press into occlusion

    Remove excess cement

    when partially set

    P t i t ti ?

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    123/128

    Post-op instructions ?

    Although a well-

    adapted and cemented

    crown should not come

    off under thesecircumstances, patients

    and parents should be

    warned of the

    possibility

    Pain & analgesics

    M i Cli i l V i ti

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    124/128

    Managing Clinical Variations

    Space Loss

    M i S L

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    125/128

    Managing Space Loss

    May need to increase

    the buccal and lingual

    reductions

    May need to compresscrown form on mesial

    and distal with Howe

    pliers

    Cli i l V i ti

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    126/128

    Clinical Variations

    Back-to-back chromecrowns

    Second primary molars

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    127/128

  • 7/24/2019 9.32b19af0-7812-4395-bd96-05d5a6503363.pdf

    128/128

    Any Questions???